We’re looking for people to take part in Diabetes and Neuropathy studies

We are currently recruiting for Diabetic Neuropathy and Small Fibre Neuropathy trials. If you are interested in taking part in one of our studies, please register your interest below and a member of our team will be touch.

Click the button below to be taken to a quick online questionnaire to check your eligibility.

Your safety and well-being is our priority. We operate under the international regulations governing clinical trials, and in full partnership with your GP.

Our comfortable, friendly new clinic is located a short walk from Barbican underground station, 8 minutes from Farringdon and 12 minutes from Liverpool street.

SPCR, Diabetes, and Diabetic Neuropathy

St Pancras Clinical Research was founded in 2016 by a group of medical experts with vast clinical trial experience, across all phases.

SPCR has extensive medical and research experience in the field of neuropathy, from ‘first-in-man’ studies, to post marketing.

Our patients have access to a range of specialist facilities and in-house consultants.

We offer the opportunity to take part in clinical trials of new medicines for the treatment of pain associated with neuropathy, in both painful diabetic neuropathy and small fibre neuropathy.

Our patients benefit from:

  • A variety of diagnostic tests
  • Early access to potential new medicines
  • Access to specialist doctors and consultants
  • Regular comprehensive check-ups
  • Reimbursement for time and travel expenses

Am I eligible to take part?

If you have diabetes, and have been diagnosed with neuropathy or you suspect you may have it, then register your interest in our Diabetes and Neuropathy clinical trials by completing the questionnaire below.

Your form will be assessed by our dedicated Patient Engagement Team who will review your suitability.

Each clinical trial has a strict set of criteria to determine eligibility which exists to ensure patient safety. If you are suitable based on your questionnaire, a member of the team will be in touch to talk to you in more detail about your symptoms and the trial options available to you.